Dentistry and the cancer patient: Part 2--Oral health management of the chemotherapy patient.
The increase in the incidence of head and neck cancer has been accompanied by a more widespread use of chemotherapy. As a result, the dental community has frequent contact with patients who are undergoing or have undergone chemotherapy. In many of these patients, immunosuppression leads to an increased risk of infection, and the chemotherapeutic agents themselves can cause a variety of oral complications. The dentist must be familiar with available treatments for managing these conditions and for preventing further deterioration of oral and systemic health.
Semba
S E
SE
Department of Periodontics, Wilford Hall Medical Center, Lackland Air Force Base, Texas, USA.
Mealey
B L
BL
Hallmon
W W
WW
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001424:Bacterial Infections / Q000188:drug therapy; D017742:Dental Care for Chronically Ill; D006801:Humans; D016867:Immunocompromised Host; D009061:Mouth Mucosa / Q000187:drug effects; D009181:Mycoses / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy; D006472:Oral Hemorrhage / Q000517:prevention & control; D010510:Periodontal Diseases / Q000628:therapy; D013280:Stomatitis / Q000139:chemically induced; D014081:Tooth Extraction; D014777:Virus Diseases / Q000188:drug therapy
D000970:Antineoplastic Agents